and Rho by deregulated exchange factors induces malignant transformation as well as morphological changes (Khosravifar et al., 1994; Michiels et al., 1995) has suggested that these GTPases may regulate nuclear as well as cytoplasmic effects. Three recent papers in Cell (Coso et al., 1995; Minden et al., 1995; Hill et al., 1995) describe a link from these GTP-binding proteins to the nucleus and, for Cdc42 and Rat, to a mitogen-activating protein kinase (MAPK) cascade. Coso et al. (1995) and Minden et al. (1995) made extensive use of transient transfection assays with an epitopetagged cJun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) cDNA clone as reporter. Protein kinase assays of the recovered tagged JNK were used to monitor activity of the MAPK pathway that leads to the JNKs (in order, MAP or extracellular-regulated kinase [ERK] kinase 1 [MEKKl] , SAP or ERK kinase [SEKIIMAPK kinase 4 [MKK4] , and JNK; Figure 1 ). By cotransfecting various mutants of Cdc42, Racl, and RhoA that lock the small GTPase into a constitutively active or inactive state, Coso et al. and Minden et al. were able to show that JNK activation is dependent on Cdc42 and Racl , but not RhoA. In addition, transfection of a RhoGAP, which inactivates all Rho family members, reduces activation of JNK by cytokines, and transfection of Dbl or Ost, GDSs for Cdc42 and also RhoA, efficiently activates JNK. The Dbl-induced activation of JNK was abolished upon cotransfection of JNK with an N-terminal region of the serinelthreonine kinase PAK85 (Manser et al., 1994; Martin et al., 1995) which includes a Cdc42IRacbinding domain and may be expected to block signaling from Dbl through Cdc42 by titrating the GTPase. This result indicates that the Dbl activation of JNK is mediated through its activation of Cdc42, not RhoA. Minden et al. also MEKKl (a JNK kinase kinase) and the subsequent members of the kinase cascade in much the same way that Ras activates Raf (a MAPK kinase kinase) and its downstream effects ( Figure 1 ). Just as Ras directly contacts Raf, the link from Cdc42 and Racl to MEKKl may be direct, with Cdc42 and Racl binding to MEKKl But the present assumption is that the interaction is mediated by PAK65.
PAK65 was identified as a Cdc42-and Rat-binding protein (Manser et al., 1994; Martin et al., 1995) . Binding of PAK65 to Cdc42 and Rat is direct, requires active (GTPbound) Cdc42 or Rat, and stimulates the catalytic activity of the kinase (autophosphorylation and phosphorylation of an exogenous substrate, myelin basic protein). Intriguingly, the sequence of PAK65 resembles that of budding yeast StePO, an upstream activator of MAPK cascades that are required for pheromone and invasive growth responses (Herskowitz, 1995) . The homology of PAK65 to Ste20 and StePO's link to a MAPK cascade suggests the possibility that PAK65 will couple Cdc42/Rac to a MAPK cascade. But, as with the link of Ste20 to its downstream effector Stell, it remains to be determined whether PAK65 directly activates MEKKl.
Whereas the cytoskeletal effects of Cdc42 and Racl are distinct, the evidence suggests that both proteins activate the same kinase cascade. This conclusion is based in part on the overexpression of dominant inhibitory and activated mutants. Of particular concern, the effects of activated mutants and their normal counterparts may differ. The mutant proteins may have higher levels of GTP loading than normal counterparts, are active permanently rather than temporarily, and may be abnormally localized, permitting them to interact with effecters they do not normally contact. Therefore, demonstration of physiological regulation of the GTPases is crucial, but may be quite difficult experimentally.
And what of the third family member, RhoA? RhoA does not regulate the JNK pathway. Rather, as demonstrated by Hill et al. (1995) RhoA is required for signaling to the serum response factor (SRF) by serum, lysophosphatidic acid (LPA), and aluminum fluoride (AIF,-), agents that act through a pertussis toxin-sensitive heterotrimeric G protein.
At the c-Fos serum response element (SRE), activated ternary complex factor (TCF) and activated SRF cooperate for maximal gene expression (Treisman, 1994) . Growth factors signal to TCF through the Ras-Raf-Erk pathway. Mutants of the c-fos promoter that cannot bind TCF nonetheless are still responsive to serum, LPA, and AIF4-. This response is independent of the Ras-Raf-Erk pathway but dependent on SRF. Hill et al. have identified Rho family members as regulators of this TCF-independent, SRFdependent signaling pathway.
In a series of elegant experiments, Hill et al. demonstrated that activated versions of three Rho family members, Cdc42Hs Racl, and RhoA, induce transcription from a TCF-independent c-fos reporter gene and that the TCF-and SRF-dependent signaling pathways are likely to converge at the SRE and to act synergistically at the SRE. Moreover, use of bacterial C3 exoenzyme, which specifically inhibits RhoA, indicated that the activation of SRF by Cdc42 and Racl occurs independently of RhoA, whereas activation by extracellular agents, such as LPA, depends on RhoA. The RhoA dependence of SRF activation is unlikely to be an artifact of the cytoskeletal disruption caused by RhoA inhibition, since SRF is activated, not inhibited, in cytochalasin-treated cells. This suggests that at least two signaling pathways mediated by Rho family members converge on SRF.
Clearly, the involvementof RhoAdistinguishesSRFactivation from that of JNK, and external stimuli that activate JNK do not necessarily activate SRF. This study suggests the existence of novel signaling pathways to SRF that are dependent on Rho family members. How are the effects of Rho family members transmitted to SRF? It is tempting to speculate that, analogous to the Cdc42/Racl link to JNK, RhoA will also couple to a MAPK cascade, perhaps by activation of a Rho-specific StePO or MEKK homolog (Figure 2) .
With the identification of Rho family members as activators of MAPK cascades, it seems likely that many or all MAPK pathways might be controlled by small GTPases, possibly in cooperation with "second signals" provided by other kinases or small molecules. Second signals (coactivators) are likely to play an important role in the RasRaf pathway. RasGTP acts to localize Raf to the plasma membrane, where a second, ill-defined event takes place to activate the Raf catalytic activity (Leevers et al., 1994) . As with Ras and Raf, GTP-bound Cdc42IRacl may provide a permissive environment for PAK65 activation, for example, by localizing PAK65 to an appropriate cellular compartment, where a second, regulated signal may be delivered by a protein kinase or, perhaps, a phospholipid metabolite. A requirement for a second signal might explain apparent roles for Ras in JNK activation and RhoAdependent SRF activation, although Ras could alternatively regulate SRF by producing a substrate for a RhoA-activated enzyme (Hill et al., 1995) . Additional studies are sure to be forthcoming to determine what role, if But since Rho family members mediate the stress response through activation of a MAPK cascade, it is tempting to speculate that activation of the SRF by Rho family members will also involve a MAPK cascade, perhaps initatiated by a novel p21-activated kinase (PAK).
any, second activating signals play in the kinase cascades activated by Rho family members. The activities of Ras, Cdc42, Racl, and RhoA seem to be interdependent.
Growth factors and constitutively active Ras stimulate stress fiber formation by activating Rat and Rho, and membrane ruffling depends on Rat . Somewhat paradoxically, experiments with dominant negative mutants, toxin, and GAPS indicate that Racl and RhoA are also required for morphological transformation by Ras Prendergrast et al., 1995) , a process that involves cell rounding and loss of stress fibers. Cdc42 also appears to activate Rat and Rho (Nobes and Hall, 1995) . Therefore, it is possible that the Rat-and Rho-dependent nuclear events and the Cdc42/Rac-dependent JNK cascade are also regulated by Ras.
The possible links between these small GTPases are rapidly being discovered. Phospholipid metabolites or direct protein interactions may be important. In mammalian cells, Racl may be activated by specific phdsphoinositides that are produced by phosphatidylinositol 3-kinase (Hawkins et al., 1995) . That enzyme may be activated directly by Ras (Rodriguez-Viciana et al., 1994) or may be activated indirectly in Ras-transformed cells by autocrine stimulation. Rho, in turn, is activated by arachidonic acid metabolites produced when Racl is activated (Peppelenbosch et al., 1995) . And the discovery of Cdc42-and Raclstimulated protein kinases raises the possibility that protein phosphorylation will link one small GTPase to another (Figure 3) .
The discovery of transcriptional regulation by Rho family GTPases helps explain the common isolation of RhoGDS genes as oncogenes, able to cause complete morphologic and mitogenic transformation (e.g., Horii et al., 1994 or are there other cytoplasmic effecters? Many of the cytoskeletal changes required for cell shape alterations and movement, such as the production and reabsorption of microspikes(Cdc42dependent), lamellipodia(Racdependent), and adhesion contacts and stress fibers (RhoA dependent), occur on a time scale of minutes, so these cy toskeletal alterations may be coordinated between small molecular mass GTP-binding proteins at the cell surface, without involving the nucleus. Defining the mechanisms for cross-talk between small molecular mass GTP-binding proteins, as well as understanding how one particular GTP-binding protein regulates events in different cellular compartments (Cell surface, nucleus) coordinately or mdependently, depending on stimulus, should prove to be an exciting area for future experiments.
